Cytokine‐regulated Th17 plasticity in human health and diseases-Reference-Cited by-同舟云学术

Cytokine‐regulated Th17 plasticity in human health and diseases

Published:2020-11-06 Issue:1 Volume:163 Page:3-18
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Cerboni Silvia¹,Gehrmann Ulf¹,Preite Silvia²,Mitra Suman³^ORCID

Affiliation:

1. Translational Science and Experimental Medicine Research and Early Development, Respiratory and Immunology (R&I BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

2. Bioscience, In vivo, Research and Early Development Respiratory & Immunology (R&I BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

3. CNRS, INSERM, CHU Lille, Institut pour la Recherche contre le Cancer de Lille UMR9020 – UMR‐S 1277 – CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies Univ. Lille Lille France

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13280

Reference164 articles.

1. Memory CD4+ T Cells in Immunity and Autoimmune Diseases

2. Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response

3. Heterogeneity of Human CD4+ T Cells Against Microbes

4. Heterogeneity of Cytokine Secretion Patterns and Functions of Helper T Cells

5. Human TH1 and TH2 subsets: doubt no more

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Review of biological activities: A plant of traditional Chinese tonic;Journal of Ethnopharmacology;2024-10

3. IL-26 Potentiates Type 2 Skin Inflammation in the Presence of IL-1β;Journal of Investigative Dermatology;2024-07

4. Deciphering Molecular Mechanisms of Cutaneous Leishmaniasis, Pathogenesis and Drug Repurposing through Systems Biology;IRAN BIOMED J;2024

5. First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers;BMC Medicine;2024-06-21